UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 15, 2021
LAWSON PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 0-10546 | 36-2229304 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
8770 W. Bryn Mawr Ave., Suite 900, Chicago, Illinois | 60631 | |||
(Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code) (773)304-5050
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading | Name of each exchange on which registered | ||
Common stock, $1.00 par value | LAWS | NASDAQ Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Appointment of Director
On February 15, 2021, the Board of Directors (the “Board”) of Lawson Products, Inc. (the “Company”) appointed Bianca Rhodes to the Board with a term expiring at the Company’s 2021 annual meeting of stockholders, at which time the Company anticipates that Ms. Rhodes will be nominated to serve for an additional term.
Ms. Rhodes, 62, has served as the President and Chief Executive Officer of Knight Aerospace Medical Systems, LLC, a global leader in custom air medical transport products, since 2014. Prior to that time, she founded CrossRhodes Consulting where she advised private enterprises on financial and operating issues helping them to raise capital and structure buyouts while also managing a family real estate business.
Ms. Rhodes began her career as a commercial banker with the National Bank of Commerce in San Antonio and later joined TexCom Management Services, a computer leasing company. At TexCom she was instrumental in the sale of the Company to Intelogic Trace (NYSE:IT) where she became the CFO. Additionally, she has served as CFO of Kinetics Concepts Inc. (NASDAQ:KNCI), a global corporation that produces medical technology for wounds and wound healing. During her tenure there, she engineered a successful turnaround, significantly increasing the company’s value, prior to going private.
Ms. Rhodes is a 1981 graduate of the McCombs School of Business at the University of Texas and received a BBA in Finance. She serves on a number of charitable boards in San Antonio and is also a member of the Board of Directors of Dura Software.
In connection with her appointment to the Board, Ms. Rhodes became eligible to receive compensation for non-employee directors in accordance with the Company’s customary practices.
There are no family relationships between Ms. Rhodes and any director or other executive officer, nor are there any transactions to which the Company was or is a participant and in which Ms. Rhodes has a material interest subject to disclosure under Item 404(a) of Regulation S-K. There are no arrangements or understandings between Ms. Rhodes and any other persons pursuant to which she was selected to be a director.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit No. | Exhibit Description | |
99.1 | Press release dated February 17, 2021 | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL) |
EXHIBIT INDEX
Exhibit | Exhibit Description | |
99.1 | Press release dated February 17, 2021 | |
104 | Cover Page Interactive Data File (formatted as Inline XBRL) |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LAWSON PRODUCTS, INC. (Registrant) | ||||||
Date: February 17, 2021 | By: | /s/ Ronald J. Knutson | ||||
Name: | Ronald J. Knutson | |||||
Title: | Executive Vice President, Chief Financial Officer, Treasurer and Controller |